Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13643 | 759 | 44.6 | 74% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
141 | 22456 | HEPCIDIN//HEMOCHROMATOSIS//IRON DEFICIENCY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | IRON METAB CHELAT PROGRAM | Address | 35 | 54% | 6% | 45 |
2 | PYRIDOXAL ISONICOTINOYL HYDRAZONE | Author keyword | 33 | 75% | 3% | 24 |
3 | TRIAPINE | Author keyword | 23 | 69% | 3% | 20 |
4 | 3 AP | Author keyword | 21 | 90% | 1% | 9 |
5 | 3 AMINOPYRIDINE 2 CARBOXALDEHYDE THIOSEMICARBAZONE | Author keyword | 15 | 88% | 1% | 7 |
6 | TRIAPINE R | Author keyword | 9 | 83% | 1% | 5 |
7 | IRON CHELATOR | Author keyword | 8 | 17% | 6% | 42 |
8 | IRON CHELATORS | Author keyword | 7 | 17% | 5% | 37 |
9 | MOL PHARMACOL PATHOL PROGRAM | Address | 5 | 33% | 2% | 12 |
10 | IRON METAB CHELAT GRP | Address | 4 | 36% | 1% | 9 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EFFECTIVE ANTIPROLIFERATIVE AGENTS | 109 | 71% | 12% | 89 |
2 | PYRIDOXAL ISONICOTINOYL HYDRAZONE | 64 | 44% | 14% | 110 |
3 | 3 AMINOPYRIDINE 2 CARBOXALDEHYDE THIOSEMICARBAZONE | 40 | 64% | 5% | 39 |
4 | ANTINEUROBLASTOMA ACTIVITY | 38 | 93% | 2% | 14 |
5 | SELECTIVE ANTITUMOR ACTIVITY | 30 | 54% | 5% | 39 |
6 | RIBONUCLEOTIDE REDUCTASE INHIBITOR | 28 | 50% | 5% | 41 |
7 | OVERLOAD DISEASE | 27 | 72% | 3% | 21 |
8 | MALIGNANT MELANOMA CELL | 25 | 77% | 2% | 17 |
9 | IRON CHELATORS | 18 | 16% | 13% | 102 |
10 | ISONICOTINOYL HYDRAZONE CLASS | 16 | 56% | 3% | 20 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The evolution of iron chelators for the treatment of iron overload disease and cancer | 2005 | 305 | 220 | 31% |
Iron Chelators for the Treatment of Cancer | 2012 | 28 | 128 | 45% |
Iron and cancer: more ore to be mined | 2013 | 70 | 184 | 16% |
Thiosemicarbazones from the Old to New: Iron Chelators That Are More Than Just Ribonucleotide Reductase Inhibitors | 2009 | 93 | 163 | 43% |
Novel Chelators for Cancer Treatment: Where Are We Now? | 2013 | 27 | 294 | 32% |
Chelators at the cancer coalface: Desferrioxamine to triapine and beyond | 2006 | 68 | 64 | 55% |
Cancer cells with irons in the fire | 2015 | 1 | 67 | 22% |
Thiosemicarbazones: the new wave in cancer treatment | 2009 | 26 | 33 | 79% |
The role of iron in cell cycle progression and the proliferation of neoplastic cells | 2002 | 222 | 155 | 28% |
Iron Deprivation in Cancer-Potential Therapeutic Implications | 2013 | 14 | 109 | 43% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IRON METAB CHELAT PROGRAM | 35 | 54% | 5.9% | 45 |
2 | MOL PHARMACOL PATHOL PROGRAM | 5 | 33% | 1.6% | 12 |
3 | IRON METAB CHELAT GRP | 4 | 36% | 1.2% | 9 |
4 | RENAL INFECT DIS | 2 | 43% | 0.4% | 3 |
5 | OXYRAD GRP | 2 | 24% | 0.8% | 6 |
6 | CHIMIOSENSIBIL PALUDISME | 1 | 100% | 0.3% | 2 |
7 | IRON METABOL CHELAT PROGRAM | 1 | 100% | 0.3% | 2 |
8 | MET BIOL | 1 | 12% | 1.4% | 11 |
9 | METALS BIOL | 1 | 33% | 0.3% | 2 |
10 | CYTOL EXPT CANCEROL | 1 | 23% | 0.4% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000180945 | CHIM COORDINAT BIOORGAN BIOINORGAN//DESFERRIOXAMINE NITROXIDE RADICAL//SOY LIPOXYGENASE |
2 | 0.0000139596 | NDRG2//NDRG1//N MYC DOWNSTREAM REGULATED GENE 1 |
3 | 0.0000138769 | HYDROXYPYRIDINONES//3 HYDROXYPYRIDIN 4 ONE//HYDROXYPYRIDINONE |
4 | 0.0000136186 | DEFERASIROX//IRON OVERLOAD//DEFERIPRONE |
5 | 0.0000131596 | FERRIC SORBITOL CITRATE//FERRIC SORBITOL CITRATE FSC//NF KAPPA B EXPRESSION ACTIVATION |
6 | 0.0000115732 | TRANSFERRIN//MELANOTRANSFERRIN//TRANSFERRIN RECEPTOR |
7 | 0.0000103973 | FERRIC NITRILOTRIACETATE//SECT CHEMOPREVENT NUTR TOXICOL//MED ELEMENTOL TOXICOL |
8 | 0.0000095690 | IRON RESPONSIVE ELEMENT//IRON REGULATORY PROTEINS//IRON REGULATORY PROTEIN 1 |
9 | 0.0000094888 | THIOSEMICARBAZONE//THIOSEMICARBAZONES//THIOSEMICARBAZONE COMPLEXES |
10 | 0.0000086283 | RIBONUCLEOTIDE REDUCTASE//P53R2//TRIMIDOX |